EDN1 and glaucoma: A growing body of evidence suggests that endothelin-1 (ET-1), a 21 amino acid vasoactive peptide, is a contributor to the etiology of glaucoma and is one of the factors increased in response to elevated IOP [2], [4], [5], [6], [7], [8], [9].